What is the treatment for a shunt?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 18, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment Approaches for Different Types of Shunts

The treatment for a shunt depends on the specific type of shunt and its associated complications, with surgical intervention being the primary approach for most shunt dysfunctions.

Systemic-to-Pulmonary Artery Shunts

Acute Shunt Thrombosis

  • Acute thrombosis of a systemic-to-pulmonary artery shunt requires emergency management with:
    • Immediate anticoagulation with heparin (50-100 U/kg) 1
    • Increased systemic blood pressure using phenylephrine to maximize shunt perfusion 1
    • Controlled ventilation to optimize oxygen delivery and minimize consumption 1
    • Alternative interventions may include epinephrine (10 μg/kg), emergency catheterization for thrombus removal, or emergent sternotomy for thrombectomy 1
    • If these measures fail, ECMO may be required for stabilization 1

Risk Factors for Shunt Occlusion

  • Conditions that cause intravascular volume depletion 1
  • Persistently draining pleural effusions 1
  • Infection 1
  • Smaller shunt size (for modified Blalock-Taussig shunts) 1

Cerebrospinal Fluid (CSF) Shunts

Shunt Infection Management

  • Complete removal of the infected shunt with placement of an external ventricular drain is recommended 1
  • Appropriate antibiotic therapy based on culture results 1
  • Delayed replacement of the shunt after CSF sterilization (typically after negative cultures for 3 days off antibiotics) 1
  • Complete shunt replacement is associated with lower risk of relapse compared to partial replacement 1

Shunt Malfunction

  • For non-functioning shunts, evaluation of proximal and distal flow intraoperatively is necessary to identify the area of failure 1
  • Complete replacement may be required if the failure is due to clogging from highly proteinaceous fluid 1
  • For patients with hydrocephalus and increased intracranial pressure, initial management includes medical therapy and repeated lumbar punctures 1
  • Most patients with increased intracranial pressure will ultimately require permanent shunt placement 1

Transjugular Intrahepatic Portosystemic Shunts (TIPS)

Insufficient Shunting

  • For shunt stenosis or occlusion, progressive dilation of a controlled expansion stent is the least invasive approach 1
  • Coverage defects can be treated with angioplasty or a new stent 1
  • In exceptional cases, placement of a new shunt may be considered 1
  • Follow-up of shunt function should be performed every 6 months, typically with Doppler ultrasound 1

Excessive Shunting

  • Reduction of the shunt is recommended for:
    • Early severe liver failure 1
    • Chronic hepatic encephalopathy refractory to medical therapy 1
    • Cardiac failure refractory to medical therapy 1
  • Shunt reduction has been shown to improve hepatic encephalopathy in 92% of cases 1

Pleuroperitoneal Shunts

Indications

  • Trapped lung with large effusions refractory to chemical pleurodesis 1
  • Malignant pleural effusions when length of hospitalization needs to be minimized 1

Management of Complications

  • Shunt occlusion (occurs in 12-25% of cases) typically requires replacement of the shunt 1
  • Contraindications include pleural infection, multiple pleural loculations, and inability to compress the pump chamber 1

Patent Foramen Ovale (PFO) Shunts

Residual Shunts After Closure

  • For moderate-to-large residual shunts after percutaneous PFO closure, implantation of a second closure device is safe and effective 2, 3
  • This approach has shown complete PFO closure in up to 90% of patients at 6-month follow-up 2
  • The 24-hour post-procedure shunt is the strongest predictor of residual shunting at six months 3

General Considerations for All Shunts

  • The specific treatment approach must be tailored to the type of shunt and the underlying condition 1
  • Regular follow-up imaging is essential to monitor shunt function and detect complications early 1
  • Surgical expertise is critical for successful shunt management, particularly for complex cases 1, 4

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Implantation of a second closure device in patients with residual shunt after percutaneous closure of patent foramen ovale.

Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions, 2004

Research

Management of residual shunts after initial percutaneous patent foramen ovale closure: a single center experience with immediate and long-term follow-up.

Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions, 2010

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.